Inhibrx Biosciences, Inc. (INBX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.23B
Last updated: Nov 17, 2026 at 11:05 AM ET
Inhibrx Biosciences, Inc. (INBX) Earnings: Report Dates and Results
Inhibrx Biosciences (INBX) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Inhibrx Biosciences reported EPS of -$2.46, above the -$2.50 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
INBX has an expected report date of Mar 17, 2027.
Earnings History
Of the 10 quarters below that had an estimate, INBX beat 5 and missed 5. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 114.58% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$2.46 | -$2.50 | -$2.57 - -$2.14 | +1.60% | Beat | N/A | 2 | 0 up, 1 down | Nov 13, 2026 | $2.00M |
| Jun 30, 2026 | -$2.34 | -$2.50 | N/A | +6.40% | Beat | N/A | 1 | 0 up, 0 down | Aug 13, 2026 | N/A |
| Mar 31, 2026 | -$2.15 | -$1.20 | -$1.20 - -$1.20 | -79.17% | Miss | N/A | 1 | 1 up, 0 down | May 14, 2026 | N/A |
| Dec 31, 2025 | -$2.11 | -$1.63 | N/A | -29.45% | Miss | N/A | 1 | 0 up, 1 down | Mar 19, 2026 | N/A |
| Sep 30, 2025 | -$2.28 | -$1.72 | -$1.72 - -$1.72 | -32.56% | Miss | N/A | 1 | 1 up, 0 down | Nov 14, 2025 | N/A |
| Jun 30, 2025 | -$1.85 | -$2.60 | -$2.60 - -$2.60 | +28.85% | Beat | -101.5% | 1 | 1 up, 0 down | Aug 13, 2025 | $1.30M |
| Mar 31, 2025 | -$2.80 | -$3.12 | N/A | +10.26% | Beat | N/A | N/A | N/A | May 14, 2025 | N/A |
| Dec 31, 2024 | -$3.09 | -$1.44 | N/A | -114.58% | Miss | N/A | N/A | N/A | Mar 17, 2025 | $100000 |
| Sep 30, 2024 | -$2.84 | -$3.70 | N/A | +23.24% | Beat | N/A | N/A | N/A | Nov 14, 2024 | N/A |
| Jun 30, 2024 | $125.48 | -$1.52 | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2024 | $100000 |
| Mar 31, 2024 | -$1.44 | -$1.04 | N/A | -38.46% | Miss | N/A | N/A | N/A | Jun 3, 2024 | N/A |
Annual EPS
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | -$6.95 | N/A |
| Jun 30, 2026 | -$4.49 | N/A |
| Dec 31, 2025 | -$9.04 | N/A |
| Jun 30, 2025 | -$4.65 | -103.9% |
| Dec 31, 2024 | $118.11 | N/A |
Frequently Asked Questions About INBX
When is Inhibrx Biosciences's next earnings date?
Inhibrx Biosciences's next earnings report is expected for Mar 17, 2027.
Did INBX beat earnings estimates last quarter?
Yes. Inhibrx Biosciences reported EPS of -$2.46 for the quarter ended Sep 30, 2026, above the -$2.50 estimate, a 1.60% surprise.
What EPS do analysts expect from INBX next quarter?
The consensus EPS estimate for Inhibrx Biosciences for the quarter ending Dec 31, 2026 is -$2.84 from 5 analysts, with estimates from -$3.46 to -$2.42.
How often does INBX beat earnings estimates?
Inhibrx Biosciences beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -26.08%.
INBX pages: Overview, Earnings, Forecast, Financials, Competitors